Recent Finacing
Recent Raise
Novigenix is a Lausanne-based biotech developing LITOseek, an immuno-transcriptomic platform that derives cancer immuno‑transcriptomic profiles from blood combined with clinical data for CRC screening, patient stratification, and immunotherapy monitoring.